Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now full pipeline small index

Neurological Disorder: full-pipeline trial registry

7 of 11 indexed Neurological Disorder trials are currently recruiting.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 7 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Neurological Disorder: 11 US clinical trials tracked, 7 recruiting.

Neurological Disorder is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Forest Hills Lab, running 1 of these trials.

Enrollment posture brief

Registry condition neurological-disorder

OPEN 7 | RECR 64% | LATE 1 | EARLY 1 | RANK #1577 | SPON 1

Nearest open-share peer: Advanced Melanoma (64% recruiting · 22 trials)

Acute Pancreatitis81.8%Neurological Disorder (this)64%Acute Stroke45.5%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Neurological Disorder

Neurological Disorder lists 7 open slots (64% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Neurological Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Neurological Disorder is recruiting above its size-band peers.

    7 of 11 indexed trials (63.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Neurological Disorder trials is spread across many organizations.

    Forest Hills Lab accounts for 1 of 11 trials (9.1%). 11 distinct sponsors appear on at least one study for this condition label.

  3. Typical Neurological Disorder enrolment sits around 100 participants.

    Median target enrolment is 100 among the 11 trials that report a genuine target (sentinel values excluded). 4 of those (36.4%) plan for fewer than 100 participants.

  4. Neurological Disorder research is mostly interventional.

    8 interventional and 3 observational studies make up this index (72.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31

Open and recent trials

11 total, page 1 of 1

RECRUITING 3,500 participants

Wearable Devices and Biomarkers Project (Healthiomics)

CureScience

NCT05106725

RECRUITING 1,000 participants

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

National Institute of Mental Health (NIMH)

NCT01778504

RECRUITING 350 participants

Families Filming Infants Learning Movement

Ann & Robert H Lurie Children's Hospital of Chicago

NCT06278961

RECRUITING Phase 3 100 participants

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

Vanda Pharmaceuticals

NCT05361707

RECRUITING NA 100 participants

Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care

University of Wisconsin, Madison

NCT06643598

RECRUITING NA 50 participants

Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

Alexander T. Yahanda

NCT07218133

RECRUITING NA 20 participants

Transcutaneous Stimulation for Neurological Populations

University of Washington

NCT04467437

ACTIVE NOT RECRUITING NA 200 participants

Multidisciplinary Lifestyle Interventions for Neurological Disorders During the Silent Phase

Vineet Punia MD

NCT05984056

ACTIVE NOT RECRUITING NA 100 participants

Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging

University of Pennsylvania

NCT04436068

COMPLETED Phase 1 40 participants

Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects

Forest Hills Lab

NCT05938452

COMPLETED NA 15 participants

Preventing Chronic Depression and PTSD in Stroke Patients Admitted to the Neuroscience Intensive Care Unit (NICU) and Their Family Caregivers

Massachusetts General Hospital

NCT02797509

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Named interventions

Most-linked intervention names on Neurological Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Glyceryl Tribenzoate Drug
1 trials
Psychosocial Skills-Based Intervention Behavioral
1 trials
Hyperfine MRI scan Device
1 trials
Multidisciplinary lifestyle interventions Behavioral
1 trials
Auricular vagus nerve stimulation Device
1 trials
Transcutaneous Spinal Stimulation Device
1 trials
Abecedarian Approach Behavioral
1 trials
Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension Drug
1 trials

US sites by state

Facility locations filed on Neurological Disorder trials. A trial with sites in several states counts in each.

California 2 trials
Wisconsin 1 trials
Washington 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
New Jersey 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Neurological Disorder page

11 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 7 Neurological Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Forest Hills Lab sponsors the most Neurological Disorder trials on record, review their full trial history before evaluating a specific study. See Forest Hills Lab's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurological Disorder condition card totals 11 registered trials; most-linked intervention Glyceryl Tribenzoate; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.